Last reviewed · How we verify

GFH312 200 mg

Zhejiang Genfleet Therapeutics Co., Ltd. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic nameGFH312 200 mg
Also known asGFH312
SponsorZhejiang Genfleet Therapeutics Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results